ClinTec opens fully registered offices in China, Singapore and Thailand for clinical research

Jun 16 2011

UK based Global Clinical Research Organisation (CRO), ClinTec International has continued its international expansion by opening fully registered offices in China, Singapore and Thailand - consolidating its presence in the Asia Pacific region. Over the next quarter, strategic moves into South Korea, Taiwan, Malaysia and Indonesia will also take place. The expansion has also been strengthened by the recent appointment of several regional CRAs plus Mary Pan, Director Asia Pacific who has over 12 years international experience in clinical research.

ClinTec CEO, President and Founder, Dr Buttar commented, "Since ClinTec was established in 1997, entering into the emerging markets has always proved to be a huge success for us and we expect the same from the Asia Pacific market. Several multinational companies in pharmaceutical and clinical nutrition product development are already working in partnership with ClinTec to undertake significant clinical research projects across the region.

Whilst other CROs have tended to acquire local companies in Asia Pacific to expand their geographical presence, ClinTec has remained true to its strategy of organic growth and employing its own local staff members and therefore guaranteeing the same ClinTec culture, values and international standards in the region from the start of its operations. This has also allowed us to offer clients a high degree of flexibility in choosing the most suitable personnel for their projects, aligning our growth with those of our clients. Following a decade of building a strong regional hub in Bangalore, India, we are now tactically located in further Asian countries to meet big pharma's global need for core resources including talent, experience and a wealth of localised clinical research knowledge."

In the current economic climate, pharmaceutical companies are searching for new ways of working and delivering global solutions. As such, they are increasingly looking to enter new markets where revenues have not yet been fully tapped, and for partnerships with global CROs capable of facilitating world-wide multicentre clinical research needs. In the past 2 years, ClinTec has entered 25 new countries worldwide and its success has been founded on global experience, combined with local knowledge.